C. Slabber

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

Meinolf Karthaus, Albrecht Kretzschmar, H. Kröning et al. · Annals of Oncology · 2005 · 219 citations · Full text

Venous Disease, Oncology, Venous Thrombosis +10

A Randomized Study of Radiotherapy Alone Versus Radiotherapy Plus 5-Fluorouracil and Platinum in Patients With Inoperable, Locally Advanced Squamous Cancer of the Esophagus

C. Slabber, Johan S. Nel, L. Schoeman et al. · American Journal of Clinical Oncology · 1998 · 84 citations

Squamous Cell Cancer, Surgical Oncology, Esophagus +12

The <scp>RNA</scp> helicase <scp>DHX</scp> 9 establishes nucleolar heterochromatin, and this activity is required for embryonic stem cell differentiation

Sergio Leone, Dominik Bär, C. Slabber et al. · EMBO Reports · 2017 · 52 citations · Full text

First line therapy with paclitaxel (Taxol®) and pegylated liposomal doxorubicin (Caelyx®) in patients with metastatic breast cancer: a multicentre phase II study

Daniel Vorobiof, Bernardo L. Rapoport, Martin Chasen et al. · The Breast · 2004 · 47 citations · Full text

Metastatic Breast Cancer, Oncology, Breast Oncology +13

Phase II Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients With Platinum-Sensitive and Partially Platinum-Sensitive Metastatic Ovarian Cancer

Bernardo L. Rapoport, Daniel Vorobiof, C. Slabber et al. · International Journal of Gynecological Cancer · 2009 · 22 citations